REFERENCES
- Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004;137:486–495
- Friedman DS, O’Colmain BJ, Munoz B, et al. The prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564–572
- Bureau of the Census. Washington, DC: US Department of Commerce; 2006. US Department of Commerce. Interim projections: population under age 18 and 65 and older: 2000, 2010, and 2030. Accession date 13 May 2015. Available at: http://www.census.gov/population/www/projections/projectionsagesex.html
- Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 2004;122:598–614
- Hyman L, Neborsky R. Risk factors for age-related macular degeneration: an update. Curr Opin Ophthalmol 2002;3:171–175
- Liutkevičienė R, Lesauskaitė V, Ašmonienė V, et al. Factors determining age-related macular degeneration: a current view. Medicina (Kaunas) 2010;46:89–94
- Tatar O, Adam A, Shinoda K, et al. Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy. Br J Ophthalmol 2007;91:1183–1189
- Seitzman RL, Mahajan VB, Mangione C, et al. Estrogen receptor alpha and matrix metalloproteinase 2 polymorphisms and age-related maculopathy in older women. Am J Epidemiol 2008;167:1217–1225
- Marin-Castano ME, Elliot SJ, Potier M, et al. Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest Ophthalmol Visual Sci 2003;44:50–59
- Price SJ, Greaves DR, Watkins H. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 2001;27:7549–7558
- Berglin L, Sarman S, van der Ploeg I, et al. Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice. Invest Ophthalmol Visual Sci 2003;44:403–408
- Kvanta A, Shen WY, Sarman S, et al. Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization. Curr Eye Res 2000;21:684–690
- Hussain AA, Lee Y, Zhang JJ, Marshall J. Disturbed matrix metalloproteinase activity of Bruch’s membrane in age-related macular degeneration. Invest Ophthalmol Visual Sci 2011;52:4459–4466
- Peasey A, Bobak M, Kubinova R, et al. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health 2006;6:255–265
- Grabauskas V, Miseviciene I, Klumbiene J, et al. Prevalence of dyslipidemias among Lithuanian rural population (CINDI program). Medicina (Kaunas) 2003;39:1215–1222
- Lesauskaite V, Macijauskiene J, Rader E. Challenges and opportunities of health care for the aging community in Lithuania. Gerontology 2006;52:40–44
- Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 2001;132:668–681
- Ortak H, Demir S, Ateş O, et al. The role of MMP2 (-1306 C > T) and TIMP2 (-418 G > C) promoter variants in age-related macular degeneration. Ophthamol Genet 2013;34:217–222
- Plantner JJ, Jiang C, Smine A. Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration. Exp Eye Res 1998;67:637–645
- Liutkeviciene R, Lesauskaite V, Sinkunaite-Marsalkiene G, et al. The role of matrix metalloproteinases polymorphisms in age-related macular degeneration. Ophthalmic Genet 2015;36:149–155
- Cousins SW, Marin-Castano ME, Espinosa-Heidmann DG, et al. Female gender, estrogen loss, and sub-RPE deposit formation in aged mice. Invest Ophthalmol Visual Sci 2003;44:1221–1229
- Steen B, Sejersen S, Berglin L, et al. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Visual Sci 1998;39:2194–2200
- Chau KY, Sivprasad S, Patel N, et al. Plasma levels of matrix metalloproteinases-2 and -9 in age-related macular degeneration. J Hum Hypert 2003;17:119–124
- Zeng R, Wen F, Zhang X, Su Y. Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration. Molec Vision 2013;19:729–736
- Chaer RA, Billeh R, Massad MG. Genetics and gene manipulation therapy of premature coronary artery disease. Cardiology 2004;101:122–130